Indore, IN: Bizwit Research & Consulting LLP’s Recent Analysis of the Global Gene Therapy Market is poised to raise up to USD 24.3 Billion by 2029. Gene therapy is a medical technique that involves manipulating the genes within an individual’s cells to treat or prevent disease. The goal of gene therapy is to introduce, replace, or correct faulty or missing genetic material with the aim of restoring normal cellular function. The key factors driving the market growth are rising rates of cancer, uncommon diseases, the growing prevalence of genetic disorders, potential cures for previously untreatable diseases, and other medical conditions that are anticipated to support the market growth during the forecast period.
Geographically, the global Gene Therapy Market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America is projected to have the largest revenue market share during the forecast period due to the presence of leading market players, increasing government investment to support research and development activities, and rapid development of advanced gene therapy products. Whereas, Europe is the most lucrative and fastest developing region for Gene Therapy Market due to the availability of several gene therapy products that are used to treat cancer and a sizable patient base.
The global Gene Therapy Market is highly competitive owing to the presence of several key manufacturers such as Amgen Inc., Biogen Inc., Bluebird Bio Inc., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd, Hoffmann-La Roche Ltd, and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Gene Therapy Market is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030.
- In the Application segment, oncological disorders are accounted as the leading market segment in 2022. The market is anticipated to increase in the approaching years due to the availability of several gene therapy products that are used to treat cancer and a sizable patient base.
- North America is anticipated to drive regional growth owing to the rise in the prevalence of chronic diseases in the region.
- Europe is expected to grow at a higher rate followed by North America during 2023-2030.
Bizwit Research & Consulting LLP has considered the following segments for the study:
By Vectors:
- Viral Vectors
- Non-viral Vectors
By Delivery Method:
- In Vivo
- Ex Vivo
By Application:
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Others
By Gene Type:
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Receptors
- Others
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with a chain of industry analysts to analyze the market trends and their future impact in order to estimate and forecast different business segments and markets. Bizwit incorporates big data, expert analysis, and a huge industry database to deliver client-focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecasts. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain, and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
